Work

Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial

Year: 2023

Type: article

Study design: Clinical Trial

Source: The Lancet Child & Adolescent Health

DOI: 10.1016/s2352-4642(23)00031-7

Authors: Eric M Thompson, Daniel Landi, Michael C Brown, Henry S Friedman, Roger McLendon, James E Herndon, Evan Buckley, Dani P Bolognesi, Eric Lipp, Kristin Schroeder, Oren J Becher, Allan H Friedman, Zachary McKay, Ashley Walter, Stevie Threatt, Denise Jaggers, Annick Desjardins, Matthias Gromeier, Darell D Bigner, David M Ashley

Institutions: Duke University, Duke Medical Center, Duke Cancer Institute, Mount Sinai Health System

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Musella Foundation For Brain Tumor Research and Information, Solving Kids' Cancer, Duke University, Andrew McDonough B+ Foundation, National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G7776075765, G9000161420, Innate Antiviral Signals for Cancer Immunotherapy

OpenAlex ID: W4361245706

FWCI: 6.941

Cites: 20

Cited by: 49

Related to: 10